Formed in 2011 by Christopher Watt and Samuel Thangiah, Life Science Integrates (LSI) brings together Senior Leaders from across the Life Sciences, including industry, academia, government and regulators; providing them with unique opportunities to be part of the conversations that set out the industry’s challenges and identify effective strategies and solutions.
Our purpose is to find novel and engaging ways to bring people together; to discuss, debate and uncover the strategic solutions to their industry’s challenges by creating environments that challenge traditional concepts and enable constructive debate around disruptive innovations, business models and supply chains to ensure that today’s ideas and concepts will become the effective therapies and diagnostics of the future. Ultimately helping to ensure that the Life Science Industry delivers the best possible outcomes for patients and carers.
Life Science Integrates has enabled the conversations that have helped shape our industry today and will set the direction for the future.
Bringing together pharma and healthcare leaders across the Pharmaceutical pipeline to address their needs, to share insights and create debate on crucial topics that influence the future of patient outcomes.
Nanoform Finland Plc (“Nanoform”), an innovative nanoparticle medicine enabling company, today announced positive interim results from its clinical study. The faster absorption data implies that small particles can indeed be powerful.
Download the new health and life sciences report now for insights on the future of HLS, compliant commerce, and why embracing digital patient engagement solutions is the key to driving loyalty, brand valuation, and revenue through COVID-19 and beyond
We continue to grapple with a global pandemic and its effect on the economy, alongside political unrest in multiple countries and governmental decisions that will have monumental implications for countries across the globe.
